This 2020 update on drug-related infectious diseases from the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020. It highlights some recent innovative responses to the problem and argues that early diagnosis through testing as well as improving links to treatment and care are crucial steps towards reaching global health goals.
Hepatitis C Baseline Data Review: Greater Manchester
Download
As part of the service redesign project the NHS Commissioning Service and the Commissioning Business Service conducted a baseline data review (BDR) of the hospitals in Greater Manchester that were treating hepatitis C patients. At the time of the audit (March
2008) there were three hospitals that managed the treatment of patients with Hepatitis C (HCV), in Wiggan, the Pennines and Central Manchester. these were:
The baseline audit was conducted because the information required to build the business case for change in hepatitis C was not readily available from the trusts. A data collection tool was devised by the Hepatitis C programme manager and the CBS. Following discussion with clinicians it was decided that March 2008 would capture a typical months worth of activity and provide sufficient information on which to base
the business case.
